Excalibur Health Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Real world patient database and revenues rapidly growing
Sensyne poised for accelerated international growth
 
Oxford, U.K. 27 May 2021:
Sensyne Health plc (LSE: SENS) ( Sensyne or the Company ), the Clinical AI company, today announces an update on trading for the financial year ended 30 April 2021 ( FY 2021 ), and an outlook statement.
 
UPDATE ON TRADING
·
Robust financial performance:
FY 2021 unaudited revenues of at least £9.0 million (FY 2020: £2.1 million audited).
·
Strong revenue growth driven by contracts with life sciences companies, with recognition of the majority of the £4.8 million minimum revenues from MagnifEye AI technology contract with Excalibur Health Services ( Excalibur ).
·
Cash and cash equivalents were £23.6 million (unaudited) and excludes receipt of majority of minimum revenue payments from the Exca ....

United States , New Jersey , United Kingdom , Bidhi Bhoma , Euan Brown , Jessica Hodgson , Richard Pye , Mary Jane Elliott , Oliver Jackson , Asia Pacific , Davide Salvi , St Luke University Health Network , Drug Administration , Peel Hunt , Excalibur Health Services , Phesi Inc , Sensyne Health , Bristol Myers Squibb , Colorado Center , Sensyne Health Trading , Excalibur Health , Consilium Strategic Communications , Sensyne Health Trading Update , University Health Network , Personalised Medicine , Life Science ,